Fibrosis, Liver Clinical Trial
— SMARTOfficial title:
Applicability, Reliability and Accuracy for Staging Hepatic Fibrosis: Comparison of Smart-Shear Wave Elastography and Transient Elastography
The aim of this prospective study was to evaluate the applicability and diagnostic performances of Smart-Shear wave(SSW) imaging, in comparison with Transient elastography(TE) for the staging of liver fibrosis using pathologic results as the reference standard.
Status | Recruiting |
Enrollment | 105 |
Est. completion date | June 2016 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years to 80 Years |
Eligibility |
Inclusion Criteria: 1. Patients with liver disease: plan to undergo liver surgery 2. Potential liver donors 3. Smart-Shear wave & transient elastography were performed within one month from liver surgery 4. Aged between 20 to 80 years 5. Compliance with scheduled visits, evaluation plans and other study procedures Exclusion Criteria: 1. Previous history of hepatic surgery 2. Previous history of transarterial chemoembolization 3. Huge or infiltrative tumor in the right lobe of the liver 4. Bile duct dilatation in the right lobe of the liver 5. Older than 80 years 6. The opinion of the investigator would make the patient unsuitable for enrollment |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Asan Medical Center | Seoul |
Lead Sponsor | Collaborator |
---|---|
Asan Medical Center |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Non-inferiority of Smart-Shear Wave(SSW) imaging compared to Transient elastography(TE) in diagnosis for hepatic fibrosis. | Applicability rate between Smart-Shear Wave(SSW) and Transient elastography(TE) will be compared to prove non-inferiority. Applicability rate = {[Total cases- (failure cases + non-reliable measurement cases)]/total case} * 100 (%) |
1 year | No |
Secondary | Evaluation of diagnostic accuracy to predict the degree of hepatic fibrosis. | Areas under the receiver operating curve (AUROCs) of the two techniques will be compared to estimate the probability of correctly predicting the degree of hepatic fibrosis. Substantial discordance between US elastography techniques and histologic staging will also be explored. It is defined as a difference in fibrosis stage by at least 2 points. |
1 year | No |
Secondary | The correlation between two US elastography techniques | The correlation between the two US elastography techniques will be tested using the Spearman's correlation coefficient. | 1 year | No |
Secondary | Reliability of Smart-Shear Wave(SSW) comparing diagnostic performance according to the reliable measurement index(RMI) results | Reliable measurement index (RMI) is an reliability index that computes the reliability of the calculated stiffness by analyzing the changes in shapes of propagated shear waves. The diagnostic performance of Smart-Shear wave will be assessed by comparing the RMI result. | 1 year | No |
Secondary | Precision of Smart-Shear Wave(SSW) | Precision of Smart-Shear Wave(SSW) will be assessed using the composite factors, including intraclass correlation coefficients (ICCs), within subject SD(wSD), repeatability coefficient(RC), and within subject CV(wCV). | 1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05479721 -
LITMUS Imaging Study
|
||
Not yet recruiting |
NCT05120557 -
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
|
N/A | |
Active, not recruiting |
NCT05473806 -
Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes
|
Phase 4 | |
Not yet recruiting |
NCT06463223 -
HIBOC = Hepatic Imaging Biomarkers in Obese Children
|
||
Not yet recruiting |
NCT03222167 -
Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
|
Phase 3 | |
Active, not recruiting |
NCT02344680 -
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
|
||
Not yet recruiting |
NCT05567614 -
Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection
|
||
Active, not recruiting |
NCT05402371 -
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
|
Phase 2 | |
Completed |
NCT03373396 -
Impact of Chlordecone on Active Chronic Hepatitis
|
N/A | |
Recruiting |
NCT05855031 -
The Liver Care Trial
|
N/A | |
Completed |
NCT04493346 -
Shear Wave Elastography
|
||
Completed |
NCT04380493 -
The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and Histology
|
||
Active, not recruiting |
NCT06315361 -
DIAbetes and NAFLD
|
||
Not yet recruiting |
NCT03492879 -
Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity
|
N/A | |
Not yet recruiting |
NCT06366425 -
Screening for Chronic Liver Diseases in General Population
|
N/A | |
Recruiting |
NCT04442334 -
The European NAFLD Registry
|
||
Recruiting |
NCT05692024 -
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
|
Phase 1/Phase 2 | |
Completed |
NCT03659058 -
Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR
|
N/A | |
Recruiting |
NCT05218538 -
Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.
|
||
Recruiting |
NCT06248580 -
Find HDV and Determine Its Status in Turkey
|